Maribel Díaz-Ricart

Grupo de investigación

Hemoterapia - hemostasia Group leader (R4)

mdiaz@clinic.cat 0000-0003-1122-0052

Publicaciones destacadas

Progressive endothelial cell damage in correlation with sepsis severity

Autores:
Fernandez, Sara; Palomo, Marta; Molina, Patricia; Diaz-Ricart, Maribel; Escolar, Gines;

(...)

Torramade-Moix, Sergi; Rovira, Montserrat; Carreras, Enric; Nicolas, Josep M; Castro, Pedro.

Referencia: Journal Of Thrombosis And Haemostasis 2021.
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia

Autores:
Torramade-Moix, S; Palomo, M; Jerez, D; Moreno-Castaño, AB; Escolar, G;

(...)

Cases, A; Zafar, MU; Rovira, J; Diekmann, F; Garcia-Pagan, JC.

Referencia: Cardiovascular Drugs And Therapy 2021.
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy

Autores:
Blasco, Miquel; Martinez-Roca, Alexandra; Rodriguez-Lobato, Luis G; Garcia-Herrera, Adriana; Rosinol, Laura;

(...)

Guillen, Elena; Campistol, Josep M; Carreras, Enric; Diaz-Ricart, Maribel; Palomo, Marta.

Referencia: British Journal Of Haematology 2021.
Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics

Autores:
Youssef, Lina; Miranda, Jezid; Blasco, Miquel; Paules, Cristina; Crovetto, Francesca;

(...)

Maria Campistol, Josep; Carles Garcia-Pagan, Joan; Diaz-Ricart, Maribel; Gratacos, Eduard; Crispi, Fatima.

Referencia: Scientific Reports 2021.
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium

Autores:
Martinez-Sanchez, Julia; Palomo, Marta; Torramade-Moix, Sergi; Belen Moreno-Castano, Ana; Rovira, Montserrat;

(...)

Escolar, Gines; Penack, Olaf; Rosinol, Laura; Carreras, Enric; Diaz-Ricart, Maribel.

Referencia: Bone Marrow Transplantation 2020.
Endothelial damage, inflammation and immunity in chronic kidney disease

Autores:
Diaz-Ricart, M; Torramade-Moix, S; Palomo, M; Moreno-Castaño, AB; Martinez-Sanchez, J;

Escolar, G; Pascual, G; Vera, M; Cases, A.

Referencia: Toxins 2020.
Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide

Autores:
Palomo, Marta; Vera, Manel; Martin, Susana; Torramade-Moix, Sergi; Martinez-Sanchez, Julia;

Moreno, Ana Belen; Carreras, Enric; Escolar, Gines; Cases, Aleix; Diaz-Ricart, Maribel.

Referencia: Journal Of Cellular And Molecular Medicine 2020.
Complement Activation and Thrombotic Microangiopathies.

Autores:
Palomo, Marta; Blasco, Miquel; Molina, Patricia; Lozano, Miquel; Praga, Manuel;

(...)

Manonelles, Anna; Gratacos, Eduard; Pereira, Arturo; Campistol, Josep M; Diaz-Ricart, Maribel.

Referencia: Clinical Journal Of The American Society Of Nephrology 2019.
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide

Autores:
Martinez-Sanchez, Julia; Hamelmann, Hannah; Palomo, Marta; Mir, Enrique; Belen Moreno-Castano, Ana;

(...)

Mertlitz, Sarah; Riesner, Katarina; Carreras, Enric; Penack, Olaf; Diaz-Ricart, Maribel.

Referencia: Frontiers In Immunology 2019.
Endothelial damage is aggravated in acute GvHD and could predict its development.

Autores:
Mir, E; Palomo, M; Rovira, M; Pereira, A; Escolar, G;

Penack, O; Holler, E; Carreras, E; Diaz-Ricart, M.

Referencia: Bone Marrow Transplantation 2017.

Proyectos destacados

SERINE-PROTEASES, ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK: ANTI-FXa THERAPIES. PI19/00888. IP:

Investigador/a principal: GINES ESCOLAR ALBALADEJO

Duración: 01/01/2020 - 31/12/2022
Protection of the endothelium during steroid-refractory GVHD. 03R/2019. CoIP w

Investigador/a principal: ENRIQUE CARRERAS PONS

Duración: 01/11/2019 - 31/10/2021
Grupo de Fisiología, Hemostasia y Trombosis. 2017-SGR671. Investigador Asociado

Duración: 01/01/2018 - 31/12/2020
Microchips para la evaluación global de la hemostasia en la cabecera del paciente (POC): Aplicaciones en la detección de alteraciones y en el seguimiento de las terapias antitrombóticas. DTS16/00133. Investigador Asociado.

Duración: 01/01/2017 - 31/12/2018
Enhancement of endothelial regeneration and endothelial funcion during graft versus host disease. 11R/2016. CoIP w

Investigador/a principal: ENRIQUE CARRERAS PONS

Duración: 01/11/2016 - 31/10/2019

Maribel Díaz-Ricart

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

SERINE-PROTEASES, ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK: ANTI-FXa THERAPIES. PI19/00888. IP:

Protection of the endothelium during steroid-refractory GVHD. 03R/2019. CoIP w

Grupo de Fisiología, Hemostasia y Trombosis. 2017-SGR671. Investigador Asociado

Microchips para la evaluación global de la hemostasia en la cabecera del paciente (POC): Aplicaciones en la detección de alteraciones y en el seguimiento de las terapias antitrombóticas. DTS16/00133. Investigador Asociado.

Enhancement of endothelial regeneration and endothelial funcion during graft versus host disease. 11R/2016. CoIP w

Suscríbete a la Newsletter del Clínic